van der Flier, Wiesje M.
Skoog, Ingmar
Schneider, Julie A.
Pantoni, Leonardo
Mok, Vincent
Chen, Christopher L. H.
Scheltens, Philip
Article History
First Online: 15 February 2018
Competing interests
: W.M.v.d.F. has been an invited speaker at Boehringer Ingelheim and has received grant support from Boehringer Ingelheim, Biogen MA Inc, Piramal Neuroimaging, Roche BV, Janssen Stellar and Combinostics. All funding is paid to her institution. I.S. has been a consultant for Takeda and has given paid lectures for Takeda in relation to vascular dementia. J.A.S. has been on the scientific advisory boards of Genentech, Eli Lilly and Grifols and has received consultancy fees from Navidea Biopharmaceuticals and the Michael J. Fox Foundation. C.L.H.C. has received research support from Moleac, Nutricia, Lundbeck, Eisai, GlaxoSmithKline and Merck. All funding is paid to his institution. P.S. has acquired grant support from GE Healthcare, Danone Research, Piramal and Merck and, in the past 2 years, has received consultancy and speaker fees from GE Healthcare, Novartis, Nutricia, Probiodrug, Biogen, Lundbeck, Roche and EIP Pharma. All funding is paid to his institution. All other authors declare no competing interests.